MNDL Bio
PrivateLast Round
Seed
Sep 8, 2024
Total Funding Raised
$2.1M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
MNDL Bio is a synthetic biology company that provides an AI-powered computational platform to optimize gene expression for recombinant protein production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, ML Platforms, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MNDL Bio Comparables
Compare MNDL Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avenue Biosciences | 82% | |
| Scala Biodesign | 82% | |
| ExpressionEdits | 81% |
MNDL Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 8, 2024 | ||||
| Grant | Jul 1, 2023 |
MNDL Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed |
| CPT Capital | Seed |
| Earth & Beyond Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
Grew 40% QoQ, from 10 to 14 employees.
- Jul 17, 2026
Grew 50% QoQ, from 10 to 15 employees.
MNDL Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MNDL Bio's valuation, stock price, and market status.
Is MNDL Bio a public or private company?
MNDL Bio is a private company.
What is the current stock price of MNDL Bio?
MNDL Bio is a private company with no public stock price. No recent secondary market data is available.
How much is MNDL Bio worth (valuation)?
Valuation information for MNDL Bio is not publicly available.
Can I buy MNDL Bio stock?
MNDL Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MNDL Bio's last funding round?
MNDL Bio's most recent funding round was Seed on September 8, 2024.
Who are the main investors in MNDL Bio?
Key investors in MNDL Bio include Earth & Beyond Ventures.
Will MNDL Bio IPO soon?
No public IPO plans have been announced for MNDL Bio.
How can I track MNDL Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MNDL Bio's secondary market activity and sign up for updates.